Product Information

POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.0962 per EA under NDC 70436000203. Its NADAC has been published 333 times since Jan 2, 2019.

FDA first approved this application on Jun 22, 2018. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 10 MEQ TABLET

Potassium Chloride
$0.0962per EA

Strength

750 mg/1

NDC

70436000203

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

4/23/2025

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209314

FDA Approved

6/22/2018

TE Code

AB2

On Market Since

11/15/2018

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 333 times since Jan 2, 2019, and over the history we have for it it has declined 39.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0962 per EA
All-time high$0.1784 (Nov 11, 2020)
All-time low$0.0894 (Nov 20, 2024)
Median price$0.1405
Average price$0.1409
Largest weekly change+35.0% (Aug 21, 2024)
Weeks tracked333
Tracking sinceJan 2, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-24.1%

5Y

-34.5%

All

-39.9%

Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.0962 per EA (NDC 70436000203), effective May 14, 2025.

How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 39.9%. It has been tracked across 333 weekly CMS publications since Jan 2, 2019.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?

Since Jan 2, 2019, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0894 (Nov 20, 2024) to a high of $0.1784 (Nov 11, 2020), with a median of $0.1405 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ TABLET, is $0.0838 per EA — about 13% below POTASSIUM CL ER 10 MEQ TABLET.

Who manufactures POTASSIUM CL ER 10 MEQ TABLET?

POTASSIUM CL ER 10 MEQ TABLET (NDC 70436000203) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.